Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 1

Status

Completed 5Active not recruiting 4Withdrawn 2Unknown 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Hypoxia 2Uterine Cervical Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × fluoroazomycin arabinoside × Clear all
NCT01549730 2026-04-29

Cervix Hypoxia FAZA

University Health Network, Toronto

Phase NA Active not recruiting
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03168737 2026-04-15

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
25 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting
70 enrolled
Sarcoma

Hypoxia, Sarcoma

NCT04395469 2026-03-05

FAZA PET/MRI Pancreas

University Health Network, Toronto

Phase NA Active not recruiting
20 enrolled

Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡